Smoking, drinking combo raises odds for esophageal cancer

April 25, 2014
Smoking, drinking combo raises odds for esophageal cancer
Study found having both unhealthy habits doubled risk of malignancy compared to having just one.

(HealthDay)—People who smoke and drink are nearly twice as likely to develop esophageal cancer as those with only one of those unhealthy habits, a new study indicates.

Previous research has shown that smoking and drinking are for , but this is the first study to show the risk associated with smoking and drinking combined, the investigators said.

The finding, which was based on an analysis of numerous databases, is published in the April 22 issue of The American Journal of Gastroenterology.

"Our study suggests that not only do alcohol and tobacco play an important role in the development of esophageal cancer, the combination of their use markedly increases their potency as carcinogens," study author Dr. Anoop Prabhu, of the Icahn School of Medicine at Mount Sinai in New York City, said in a journal news release.

"As a result, we as physicians should focus efforts directed at controlling the burden of esophageal cancer on those who consume both of these substances," Prabhu added.

This year, about 18,000 Americans will be diagnosed with esophageal cancer and more than 15,000 will die from the disease, according to the U.S. National Cancer Institute.

Explore further: Statins may lower esophageal cancer risk

More information: The U.S. National Cancer Institute has more about esophageal cancer.

Related Stories

Statins may lower esophageal cancer risk

June 6, 2013
(HealthDay)—Statins may lower the risk of esophageal cancer, particularly in patients with Barrett's esophagus, according to a review published in the June issue of Clinical Gastroenterology and Hepatology.

AIDS patients face risk for esophageal, stomach cancers

September 24, 2012
People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...

Team uncovers pathway linking heartburn and esophageal cancer

October 7, 2013
Got heartburn? More than 60 million adults in the U.S. have acid reflux, or heartburn, and approximately 10 percent are at risk for developing esophageal cancer, due in part to complications from Barrett's esophagus. But ...

GERD-related inflammation may contribute to esophageal cancer risk

May 10, 2012
Inflammation might be an important factor in the progression from reflux to esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological ...

Study links coffee to lower liver cancer risk

April 9, 2014
(HealthDay)—Researchers say they've discovered yet another reason to love coffee: A new study suggests that people who drink at least a cup a day have a lower risk of liver cancer compared to those who only indulge occasionally.

ACG: Physical activity linked to lower risk of esophageal cancer

October 16, 2013
(HealthDay)—Physical activity is associated with a reduced risk of esophageal cancer (EC), according to a review and meta-analysis presented at the annual meeting of the American College of Gastroenterology, held from Oct. ...

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.